Development and external validation of a machine learning prediction…
A quick blood test can now reliably distinguish a life-threatening immune condition from routine mono in children, enabling urgent treatment when it matters most.
- Lab
- Preclinical
- Early trials
- Late trials
- In practice
Changes in DNA methylation-based aging predicts brain damage and…
Signs of accelerated aging in DNA predict brain shrinkage and dementia risk, offering a measurable target for intervention studies in midlife.
NONEComparative cardiovascular efficacy of antidiabetic therapies in type…
Two common diabetes drugs tackle different heart problems: GLP-1 drugs prevent strokes and early death, while SGLT2 drugs prevent heart failure—knowing which does what helps doctors pick the right one.
NONEVibecotamab for measurable residual disease in acute myeloid leukemia…
A new antibody therapy clears pre-leukemia in some blood cancer patients while causing mostly mild side effects, expanding treatment options beyond chemotherapy.
NONEBeyond vasodilation
A non-vasodilator drug improved breathing, exercise capacity, and heart health in pulmonary hypertension patients without worsening other heart problems—a genuinely new approach.